Product Name: Human FcRn (FCGRT & B2M) Antibody (Orilanolimab, Research Use)
Catalog Number: NBR-0795
Target Name: FcRn (FCGRT & B2M)
Trade Name: Orilanolimab
Antibody Drug Description: Orilanolimab Orilanolimab (SYNT001) is an FcRn monoclonal antibody that is expected to improve the treatment of a variety of IGg-mediated rare diseases. The drug was originally developed by Syntimmune. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: FCGRT
Synonyms: alpha-chain; FCRN
Target Description: Cell surface receptor that transfers passive humoral immunity from the mother to the newborn. Binds to the Fc region of monomeric immunoglobulin gamma and mediates its selective uptake from milk. 
Ensembl: ENSG00000104870
Uniprot: P55899